TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SYN-NAT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

SYN-NAT

ST13

US500000088912528

Classe

5

Pedido

88912528

Registro

7724324

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

11/03/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

12/05/2020

Data de registro

11/03/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

11/03/2025

Última transação

11/03/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

22/09/2023

Primeiro uso no comércio

12/04/2024

Código do desenho

5

Tipo de titular

99

Localização do titular

Changsha, Hunan, CN

Examinador

HAYS, CANDACE W

Unidade examinadora

M10

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of designed letters "SYN-NAT".

Titulares e representantes

Titulares

Medoncare Pharmaceutical Co., Ltd.

Representantes

Timothy T. Wang NI, WANG & MASSAND, PLLC

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Tonics of medicines, namely, medicinal tea; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Herbs for medicinal purposes; Nutritional supplements; dietetic foods adapted for medical use, namely, dietetic drinks, dietetic crackers, dietetic sugar for medical use, dietetic sugar substitutes for medical use; Dietary and nutritional supplements; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Nutraceuticals for use as a dietary supplement; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Sanitizing preparations for commercial use

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/03/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/03/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

15/02/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

15/02/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

14/02/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

14/02/2025

IUAF

USE AMENDMENT FILED

03/12/2024

EISU

TEAS STATEMENT OF USE RECEIVED

03/12/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/04/2024

PUBO

PUBLISHED FOR OPPOSITION

02/04/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/02/2024

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

29/08/2023

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

01/03/2023

DOCK

ASSIGNED TO EXAMINER

17/01/2023

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

01/09/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

01/03/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

28/08/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

17/02/2021

GNSL

LETTER OF SUSPENSION E-MAILED

17/02/2021

CNSL

SUSPENSION LETTER WRITTEN

17/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/01/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/01/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

26/01/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

16/08/2020

GNRT

NON-FINAL ACTION E-MAILED

16/08/2020

CNRT

NON-FINAL ACTION WRITTEN

16/08/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

15/08/2020

GNSL

LETTER OF SUSPENSION E-MAILED

15/08/2020

CNSL

SUSPENSION LETTER WRITTEN

15/08/2020

DOCK

ASSIGNED TO EXAMINER

08/08/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/05/2020

NWAP

NEW APPLICATION ENTERED

15/05/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SYN-NAT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.